615 Antisense oligonucleotide-based drug development for people with cystic fibrosis carrying the 2789+5 G-to-A splicing mutation

Saved in:
Bibliographic Details
Published in:Journal of cystic fibrosis 2022-10, Vol.21, p.S340-S341
Main Authors: Oren, Y., Barchad, O. Avizur, Galai, E. Ozeri, Elgrabli, R., Mordechai, T., Blinder, T., Stanleigh, N., Kerem, E., Kerem, B.
Format: Article
Language:English
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1569-1993
1873-5010
DOI:10.1016/S1569-1993(22)01305-4